1p6j: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1p6j" size="450" color="white" frame="true" align="right" spinBox="true" caption="1p6j, resolution 2.00Å" /> '''Rat neuronal NOS hem...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1p6j.jpg|left|200px]]<br /><applet load="1p6j" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1p6j.jpg|left|200px]]<br /><applet load="1p6j" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1p6j, resolution 2.00&Aring;" />
caption="1p6j, resolution 2.00&Aring;" />
'''Rat neuronal NOS heme domain with L-N(omega)-nitroarginine-(4R)-amino-L-proline amide bound'''<br />
'''Rat neuronal NOS heme domain with L-N(omega)-nitroarginine-(4R)-amino-L-proline amide bound'''<br />


==Overview==
==Overview==
Three nitric oxide synthase (NOS) isoforms, eNOS, nNOS and iNOS, generate, nitric oxide (NO) crucial to the cardiovascular, nervous and host defense, systems, respectively. Development of isoform-selective NOS inhibitors is, of considerable therapeutic importance. Crystal structures of, nNOS-selective dipeptide inhibitors in complex with both nNOS and eNOS, were solved and the inhibitors were found to adopt a curled conformation, in nNOS but an extended conformation in eNOS. We hypothesized that a, single-residue difference in the active site, Asp597 (nNOS) versus Asn368, (eNOS), is responsible for the favored binding in nNOS. In the D597N nNOS, mutant crystal structure, a bound inhibitor switches to the extended, conformation and its inhibition of nNOS decreases &gt;200-fold. Therefore, a, single-residue difference is responsible for more than two orders of, magnitude selectivity in inhibition of nNOS over eNOS by, L-N(omega)-nitroarginine-containing dipeptide inhibitors.
Three nitric oxide synthase (NOS) isoforms, eNOS, nNOS and iNOS, generate nitric oxide (NO) crucial to the cardiovascular, nervous and host defense systems, respectively. Development of isoform-selective NOS inhibitors is of considerable therapeutic importance. Crystal structures of nNOS-selective dipeptide inhibitors in complex with both nNOS and eNOS were solved and the inhibitors were found to adopt a curled conformation in nNOS but an extended conformation in eNOS. We hypothesized that a single-residue difference in the active site, Asp597 (nNOS) versus Asn368 (eNOS), is responsible for the favored binding in nNOS. In the D597N nNOS mutant crystal structure, a bound inhibitor switches to the extended conformation and its inhibition of nNOS decreases &gt;200-fold. Therefore, a single-residue difference is responsible for more than two orders of magnitude selectivity in inhibition of nNOS over eNOS by L-N(omega)-nitroarginine-containing dipeptide inhibitors.


==About this Structure==
==About this Structure==
1P6J is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus] with ACT, ZN, HEM, H4B and DP9 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1P6J OCA].  
1P6J is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus] with <scene name='pdbligand=ACT:'>ACT</scene>, <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=HEM:'>HEM</scene>, <scene name='pdbligand=H4B:'>H4B</scene> and <scene name='pdbligand=DP9:'>DP9</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1P6J OCA].  


==Reference==
==Reference==
Line 14: Line 14:
[[Category: Rattus norvegicus]]
[[Category: Rattus norvegicus]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Flinspach, M.L.]]
[[Category: Flinspach, M L.]]
[[Category: Gomez-Vidal, J.A.]]
[[Category: Gomez-Vidal, J A.]]
[[Category: Hah, J.M.]]
[[Category: Hah, J M.]]
[[Category: Huang, H.]]
[[Category: Huang, H.]]
[[Category: Jamal, J.]]
[[Category: Jamal, J.]]
[[Category: Li, H.]]
[[Category: Li, H.]]
[[Category: Litzinger, E.A.]]
[[Category: Litzinger, E A.]]
[[Category: Poulos, T.L.]]
[[Category: Poulos, T L.]]
[[Category: Silverman, R.B.]]
[[Category: Silverman, R B.]]
[[Category: Yang, W.]]
[[Category: Yang, W.]]
[[Category: ACT]]
[[Category: ACT]]
Line 33: Line 33:
[[Category: oxidoreductase]]
[[Category: oxidoreductase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 23:31:08 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:25:44 2008''